Newsroom

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders. If you currently own Lifecore stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about...

VIENNA--(BUSINESS WIRE)--AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with MF Presented at ASH 2025...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA...

ROTTERDAM, Niederlande--(BUSINESS WIRE)--Prodalim, ein weltweit führender Anbieter von Lösungen für Säfte und Spezialzutaten, gab heute die Übernahme von René Laurent, einem führenden Hersteller von Getränkearomen, von International Flavours & Fragrances Inc. (IFF) bekannt. René Laurent wurde 1885 in der Region Grasse, der Hauptstadt der Aroma- und Duftstoffindustrie in Südfrankreich, gegründet und ist eine traditionsreiche, vertrauenswürdige Marke, die sich auf Aromen für Getränke und einz...

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL), even among those ineligible for the previous standard of care, high-dose chemotherapy followed by an autologous stem cell transplant (ASCT). Results were shared from the combined analysis of four-year data from the la...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced primary data from the pivotal Phase 3 EPCORE® FL-1 study evaluating fixed duration EPKINLY® (epcoritamab-bysp) in combination with rituximab and lenalidomide (EPKINLY + R2) in adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The study showed that treatment with EPKINLY + R2 reduced the risk of disease progression or death by 79% (HR 0.21, 95% CI: 0.14-0.31, p<0.0001) compared to standard...

RIYADH, Saudi Arabia--(BUSINESS WIRE)--Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the following medicines and indications have been renewed in the 2025 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administration (NHSA): VYVGART® (efgartigimod alfa injection) is renewed for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive; NUZYRA® (omadacycl...

TENGCHONG, Cina--(BUSINESS WIRE)--Il 2025 Tengchong Scientists Forum ha aperto le porte sabato nella Provincia di Yunnan, nel sudovest della Cina, riunendo scienziati ed esponenti del mondo accademico di grande rilievo per esaminare l'innovazione nei settori di frontiera che comprendono l'intelligenza artificiale, la biodiversità e la tecnologia quantistica. Tra i partecipanti di spicco si distinguono il premio Nobel per la fisica Konstantin Novoselov, il vincitore della Medaglia Fields Efim Ze...